Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The inaugural NDORMS Imaging Competition saw a fantastic collection of submissions of microscopic things which have a great impact in our bodies. The winners were announced at an Imaging Symposium held at the Kennedy Institute.

The competition was launched by the Institute’s Microscopy and Imaging Facility to showcase exciting imaging studies taking place across the Department. 

The Symposium included talks from Oxford researchers Prof Robin Choudhury, Dr Bart Cornelissen, Prof Shankar Srinivas and Dr Kseniya Korobchevskeya, as well as from Prof Miep Helfrich from the University of Aberdeen. The speakers discussed how state-of-the-art imaging techniques are being applied to visualise the behaviour of molecules and cells in tissues to better understand cardiovascular inflammation, tumour growth, embryogenesis and bone repair. 

In his opening remarks, Professor Michael Dustin described how Oxford’s tremendous capabilities in imaging creates unique opportunities for collaboration across scientific fields. Speaking of the Symposium he said: “This is a great opportunity to highlight outstanding imaging being done in NDORMS and to build bridges to other centres of excellence with unique capabilities in Oxford and the UK.  For example, Prof Helfrich introduced the power of 3D block face scanning electron microscopy, which is accessible to NDORMS researchers through an instrument at nearby Oxford Brookes University.”

The winning images were selected by Oxford imaging experts Andrew Jefferson, Graham Brown, Ian Dobbie and Carina Monico and announced as:

Light Microscopy (Histology)

  • Marcia Curtinha, Masson’s Trichrome Staining of Femur (joint 1st Prize)
  • Jessica Malzahn, Hope in Endometriosis (joint 1st Prize)

Advanced Epiflourescence/Confocal/MP Microscopy

  • James Felce, Basophil Swarm (1st Prize)
  • Sam Olechnowicz, Myeloma Infiltration (2st Prize)

Super-Resolution Microscopy

  • Stefan Balint, Actin Mesh in Primary T cells (joint 1st Prize)
  • Kseniya Korobchevskaya, Cell Cultured on Gelatin-Coated Glass (joint 1st Prize)

Whole Body Imaging

  • Ana Espirito Santo, Fracture Healing in Real Time (1nd Prize)
  • Houfu Leng, Osmium Stain Locates Bone Marrow Adipocytes (2nd Prize)

Electron Microscopy

  • Edward Stace, Connections (1st Prize)
  • Navraj Nagra, SEM of decellularised human debris (2nd Prize)

The winners received a £150 or £100 cash prize and a certificate presented by NDORMS investigators including Prof Andrew Carr and Prof Fiona Powrie.

The Symposium organisers Prof Michael Dustin, Dr Anjali Kusumbe and Dr Volodymyr Nechypouk-Zloy would like to thank Zeiss, Perkin Elmer, Olympus, CoolLED, K-Tec and Atlantic Imaging Limited for their kind sponsorship of the event.

 

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.